Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Emergent biosolutions, inc. symbols : EBS save search
Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024
Published: 2024-04-22 (Crawled : 12:00) - globenewswire.com
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: 5.15%
H: 12.25%
C: 5.88%
first conference financial results
Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive
Published: 2024-04-01 (Crawled : 12:00) - globenewswire.com
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: -4.85%
H: 2.18%
C: -9.8%
AQST | $4.085 -4.56% 1.1M
|
Health Technology
|
| O: -3.85%
H: 2.35%
C: -2.82%
biotech therapeutics
Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis
Published: 2024-03-28 (Crawled : 12:00) - globenewswire.com
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: 3.47%
H: 0.0%
C: 0.0%
narcan opioid save ongoing spray
Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility
Published: 2024-03-25 (Crawled : 12:00) - globenewswire.com
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: 0.83%
H: 8.44%
C: 4.53%
Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results
Published: 2024-03-06 (Crawled : 22:00) - globenewswire.com
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: -16.26%
H: 6.59%
C: 1.47%
financial results
Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conference Call on March 6, 2024
Published: 2024-02-29 (Crawled : 12:00) - globenewswire.com
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: 3.75%
H: 1.99%
C: -2.71%
conference year financial
Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO
Published: 2024-02-21 (Crawled : 12:00) - globenewswire.com
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: 11.84%
H: 91.18%
C: 59.41%
ceo
Emergent BioSolutions Awarded Procurement Contract Valued up to $235.8 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of Defense
Published: 2024-01-11 (Crawled : 13:00) - globenewswire.com
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: 3.69%
H: 0.0%
C: -6.67%
biothrax defense vaccine contract million
Emergent BioSolutions to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024
Published: 2024-01-09 (Crawled : 12:30) - globenewswire.com
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: -0.93%
H: 0.0%
C: -2.8%
conference
Emergent BioSolutions Receives $75 Million Contract Option from BARDA to Procure Doses of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted)
Published: 2023-11-28 (Crawled : 12:00) - globenewswire.com
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: 2.42%
H: 1.42%
C: -5.19%
vaccine contract
Emergent BioSolutions Receives NYSE Notice Regarding Delayed Form 10-Q Filing
Published: 2023-11-24 (Crawled : 12:30) - globenewswire.com
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: -4.31%
H: 9.0%
C: 4.5%
Soligenix Announces Recent Accomplishments And Third Quarter 2023 Financial Results
Published: 2023-11-13 (Crawled : 12:30) - prnewswire.com
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: -1.5%
H: 0.51%
C: -7.61%
SNGX | $0.393 -1.75% 310K
|
Health Technology
|
| O: 4.75%
H: 0.0%
C: -5.44%
financial results
Emergent BioSolutions Reports Third Quarter 2023 Financial Results
Published: 2023-11-08 (Crawled : 23:00) - globenewswire.com
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: -4.07%
H: 6.13%
C: 1.42%
financial results
UPDATE: Emergent BioSolutions to Release Third Quarter 2023 Financial Results and Conduct Conference Call on November 8, 2023
Published: 2023-10-30 (Crawled : 21:00) - globenewswire.com
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: -0.99%
H: 7.46%
C: 3.98%
conference financial results
Emergent BioSolutions to Release Third Quarter 2023 Financial Results and Conduct Conference Call on November 2, 2023
Published: 2023-10-19 (Crawled : 11:00) - globenewswire.com
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: -0.87%
H: 0.87%
C: -3.06%
conference financial results
Emergent BioSolutions Partners with Emmitt Smith to Launch Ready to Rescue Campaign to Help Save Lives Amidst Rising Opioid Epidemic
Published: 2023-10-16 (Crawled : 11:00) - prnewswire.com
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: 0.79%
H: 0.72%
C: -2.76%
opioid save ready
Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors
Published: 2023-10-02 (Crawled : 11:00) - globenewswire.com
JNJ | News | $148.515 -0.7% 4.3M
|
Health Technology
|
| O: -1.3%
H: 0.0%
C: 0.0%
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: 0.0%
H: 0.15%
C: -7.06%
LLY | News | $735.1 -1.42% 1.2M
|
Health Technology
|
| O: -1.77%
H: 0.0%
C: 0.0%
LQDA S | $12.635 -2.43% 540K
|
Health Technology
|
| O: 0.0%
H: 0.16%
C: -1.74%
Emergent BioSolutions’ NARCAN® Nasal Spray Launches Over the Counter Making it Possible for Everyone to Help Save a Life from an Opioid Overdose Emergency
Published: 2023-08-30 (Crawled : 10:00) - globenewswire.com
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: 3.93%
H: 8.75%
C: 7.33%
narcan opioid life save spray
Kenvue Set to Join S&P 500; Advance Auto Parts to Join S&P SmallCap 600
Published: 2023-08-21 (Crawled : 22:00) - prnewswire.com
KVUE 4 | $19.17 -1.03% 12M
|
n/a
|
| O: 1.48%
H: 2.5%
C: 2.15%
SPGI | News | $414.05 0.19% 1.9M
|
Commercial Services
|
| O: 0.64%
H: 1.22%
C: 0.7%
JNJ | News | $148.515 -0.7% 4.3M
|
Health Technology
|
| O: -1.98%
H: 0.0%
C: 0.0%
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: -8.19%
H: 3.09%
C: 2.52%
DLB | $79.83 0.85% 99K
|
Consumer Services
|
| O: -0.02%
H: 0.56%
C: -2.91%
AAP | $76.77 -1.58% 410K
|
Retail Trade
|
| O: -1.76%
H: 1.6%
C: 0.51%
set
Soligenix Announces Recent Accomplishments And Second Quarter 2023 Financial Results
Published: 2023-08-21 (Crawled : 12:00) - biospace.com/
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -4.23%
SNGX | $0.393 -1.75% 310K
|
Health Technology
|
| O: 6.6%
H: 0.0%
C: -5.19%
financial results
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
CZOO | $10.52 110.82% 10M
|
CSSE 4 | $0.3181 108.86% 170M
|
Consumer Services
BOF | $1.88 60.68% 98M
|
AMST | $3.1 55.0% 66M
|
Technology Services
LICN | $0.85 51.79% 13M
|
WIMI | $1.03 41.99% 15M
|
Technology Services
SKIL 4 | $8.045 40.89% 230K
|
Information
MULN | News | $3.805 39.38% 11M
|
Information
RILY | $30.01 38.17% 11M
|
Finance
MTC | $3.04 35.71% 6.7M
|
Technology Services
Your saved searches
Save your searches and get alerts when important news are released.